Approaches to establishing angiotensin II as a neurotransmitter revisited

Hypertension

Volumn 47, Issue 3, 2006, Pages 334-336

  Diz, Debra I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; GREEN FLUORESCENT PROTEIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

BLOOD PRESSURE REGULATION; BRAIN FUNCTION; EDITORIAL; HORMONAL REGULATION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; NEUROTRANSMITTER RELEASE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; BRAIN; GENETIC PROCEDURES; HUMAN; METABOLISM; NOTE; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; BRAIN; GENETIC TECHNIQUES; HUMANS; NEUROTRANSMITTER AGENTS;

EID: 33644981851     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000203146.72879.c3     Document Type: Editorial

References (17)

1. Brosnihan KB, Diz DI, Schiavone MT, Averill DB, Ferrario CM. Approaches to establish angiotensin II as a neurotransmitter. In: Buckley JP, Ferrario CM, editors. Brain Peptides and Catecholamines in Cardiovascular Regulation. New York: Raven Press;1987:313-328.
2. Nguyen G, Burckle C, Sraer JD. The renin receptor: the facts, the promise and the hope. Curr Opin Nephrol Hypertens. 2003;12:51-55.
3. Lavoie JL, Cassell MD, Gross KW, Sigmund CD. Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model. Hypertension. 2004;43:1116-1119.
4. Kubo T, Ikezawa A, Kambe T, Hagiwara Y, Fukumori R. Renin antisense injected intraventricularly decreases blood pressure in spontaneously hypertensive rats. Brain Res Bull. 2001;56:23-28.
5. Kagiyama S, Varela A, Phillips MI, Galli SM. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension. 2001;37:371-375.
6. Lochard N, Silversides DW, van Kats JP, Mercure C, Reudelhuber TL. Brain-specific restoration of angiotensin II corrects renal defects seen in angiotensinogen-deficient mice. J Biol Chem. 2003;278:2184-2189.
7. Lavoie JL, Liu X, Bianco RA, Beltz TG, Johnson AK, Sigmund CD. Evidence supporting a functional role for intracellular renin in the brain. Hypertension. 2006;47:461-466.
8. Sinn PL, Sigmund CD. Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics. 2000;3:25-31.
9. Sakai K, Chapleau MW, Morimoto S, Cassell MD, Sigmund CD. Differential modulation of baroreflex control of heart rate by neuron- vs. glia-derived angiotensin II. Physiol Genomics. 2004;20:66-72.
10. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A. 1999;96:3975-3980.
11. Diz DI, Jessup JA, Westwood BM, Bosch SM, Vinsant S, Gallagher PE, Averill DB. Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla. Clin Exper Pharmacol Physiol. 2001;29:473-482.
12. Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI. Growth and metabolism disturbances in transgenic rats with altered renin-angiotensin system expression. Physiol Genomics. 2005;23:311-317.
13. Baltatu O, Campos LA, Bader M. Genetic targeting of the brain renin-angiotensin system in transgenic rats: impact on stress-induced renin release. Acta Physiol Scand. 2004;181:579-584.
14. Wang H, Huang BS, Ganten D, Leenen FH. Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ Res. 2004;94:843-849.
15. Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D, Bader M. Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen. Hypertension. 2001;37:408-413.
16. Huang BS, Ganten D, Leenen FH. Responses to central Na(+) and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen. Hypertension. 2001;37:683-686.
17. Vinsant S, Chappell MC, Ferrario CM, Ganten D, Diz DI. Low glial angiotensinogen is not associated with deficits in angiotensin peptides in neuronal pathways in transgenic ASrAogen rats. FASEB J. 2005;19:A1188 (Abstract).